News Results
There are 919,538 News Results
Dec 3, 2017
CHICAGO, Dec. 4, 2017 /PRNewswire/ -- CME Group, the world's leading and most diverse derivatives marketplace, today announced that November 2017 average daily volume (ADV) reached 18 million contracts, down...
Dec 4, 2017
ROTTERDAM, the Netherlands and LAGUNA HILLS, Calif., Dec. 5, 2017 /PRNewswire/ -- SkylineDx today announced the presentation of new data at the 59(th) Annual Meeting and Exposition of the American...
Dec 4, 2017
STATESVILLE, N.C., Dec. 5, 2017 /PRNewswire/ -- Kewaunee Scientific Corporation (NASDAQ: KEQU) today reported results for its second quarter of fiscal year 2018, ended October 31, 2017. Net earnings for...
Dec 17, 2017
OAK BROOK, Ill., Dec. 18, 2017 /PRNewswire/ -- TOMY International, the master toy licensee and distributor for Pokémon, announces the release of the new Pokémon Z-POWER RING and Z-CRYSTALS. The...
Dec 17, 2017
NEW YORK, Dec. 18, 2017 /PRNewswire/ -- Neurotrope, Inc. (NASDAQ: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including Alzheimer's disease (AD), today announced the appointment of...
Dec 18, 2017
BAODING, China, Dec. 19, 2017 /PRNewswire/ -- Yingli Green Energy Holding Company Limited (NYSE: YGE) ("Yingli Green Energy" or the "Company"), one of the world's leading solar panel manufacturers, known...
Dec 19, 2017
MELBOURNE, Florida, December 20, 2017 /PRNewswire/ -- Fit Pay, Inc., a wholly owned subsidiary of NXT-ID, Inc. (NASDAQ: NXTD [ https://finance.yahoo.com/q?s=nxtd ]) and Cascade Financial Technology Corp (Cascade FinTech) today...
Dec 26, 2017
PRINCETON, N.J., Dec. 27, 2017 /PRNewswire/ -- Guerbet LLC takes note of the drug safety communication(1) issued on December 19, 2017 by the U.S. Food and Drug Administration (FDA), regarding...
Jan 1, 2018
DUBLIN, Jan. 2, 2018 /PRNewswire/ -- The "The Global M2M/IoT Terminal Market - 2nd Edition" report has been added to
Jan 6, 2018
SAN DIEGO, Jan. 7, 2018 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX), a biotechnology company focused on neurological and endocrine related disorders, today announced that Christopher O'Brien, M.D., Chief Medical...
